These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 1837058
1. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors. Damsma G, Robertson GS, Tham CS, Fibiger HC. J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058 [Abstract] [Full Text] [Related]
3. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. DeBoer P, Abercrombie ED. J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558 [Abstract] [Full Text] [Related]
4. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum. Anderson JJ, Randall S, Chase TN. J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756 [Abstract] [Full Text] [Related]
5. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release. Robertson GS, Tham CS, Wilson C, Jakubovic A, Fibiger HC. J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550 [Abstract] [Full Text] [Related]
7. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide. Suarez-Roca H, Lovenberg T, Cubeddu LX. J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346 [Abstract] [Full Text] [Related]
8. Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition. Acquas E, Fibiger HC. J Neurochem; 1998 Mar; 70(3):1088-93. PubMed ID: 9489729 [Abstract] [Full Text] [Related]
9. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors. Imperato A, Obinu MC, Casu MA, Mascia MS, Dazzi L, Gessa GL. J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643 [Abstract] [Full Text] [Related]
10. D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum. Consolo S, Wu CF, Fusi R. J Pharmacol Exp Ther; 1987 Jul; 242(1):300-5. PubMed ID: 2886638 [Abstract] [Full Text] [Related]
11. Electrically-evoked dopamine and acetylcholine release from rat striatal slices perfused without magnesium: regulation by glutamate acting on NMDA receptors. Jin S, Fredholm BB. Br J Pharmacol; 1997 Aug; 121(7):1269-76. PubMed ID: 9257903 [Abstract] [Full Text] [Related]
12. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists. Huang KX, Walters JR. J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977 [Abstract] [Full Text] [Related]
13. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. Baud P, Arbilla S, Cantrill RC, Scatton B, Langer SZ. J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699 [Abstract] [Full Text] [Related]
14. A within-subjects microdialysis/behavioural study of the role of striatal acetylcholine in D1-dependent turning. Acquas E, Fenu S, Loddo P, Di Chiara G. Behav Brain Res; 1999 Sep; 103(2):219-28. PubMed ID: 10513590 [Abstract] [Full Text] [Related]
15. Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum. Zackheim J, Abercrombie ED. Neuroscience; 2005 Sep; 131(2):423-36. PubMed ID: 15708484 [Abstract] [Full Text] [Related]
16. Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat. Damsma G, Tham CS, Robertson GS, Fibiger HC. Eur J Pharmacol; 1990 Sep 21; 186(2-3):335-8. PubMed ID: 1981190 [Abstract] [Full Text] [Related]
17. The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval. De Boer P, Damsma G, Schram Q, Stoof JC, Zaagsma J, Westerink BH. Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb 21; 345(2):144-52. PubMed ID: 1349159 [Abstract] [Full Text] [Related]
18. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat. Campbell BM, Kreipke CW, Walker PD. Neuroscience; 2006 Feb 21; 137(2):505-17. PubMed ID: 16289829 [Abstract] [Full Text] [Related]
19. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. Jin S, Johansson B, Fredholm BB. J Pharmacol Exp Ther; 1993 Nov 21; 267(2):801-8. PubMed ID: 7902434 [Abstract] [Full Text] [Related]
20. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride. Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL. J Pharmacol Exp Ther; 1998 Oct 21; 287(1):167-86. PubMed ID: 9765336 [Abstract] [Full Text] [Related] Page: [Next] [New Search]